Log in to save to my catalogue

Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters

Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c73bd9faab8d4e24a621c1d9885c5d7f

Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters

About this item

Full title

Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2021-01, Vol.13 (1), p.81

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

During the COVID-19 pandemic, several repurposed drugs have been proposed to alleviate the major health effects of the disease. These drugs are often applied with analgesics or non-steroid anti-inflammatory compounds, and co-morbid patients may also be treated with anticancer, cholesterol-lowering, or antidiabetic agents. Since drug ADME-tox proper...

Alternative Titles

Full title

Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c73bd9faab8d4e24a621c1d9885c5d7f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c73bd9faab8d4e24a621c1d9885c5d7f

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics13010081

How to access this item